Stay updated on Arimoclomol in Myositis-Open Label Extension Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.

Latest updates to the Arimoclomol in Myositis-Open Label Extension Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the record history. The funding status notice and Revision: v3.4.1 text were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a general notice about a lapse in government funding and updated the page status to reflect that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for status updates. The history now shows Revision: v3.4.1 and removes the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedShow glossary option and color-coded change indicators were added; the revision label was updated from v3.3.4 to v3.4.0 and No FEAR Act data was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedThe study record history now shows an added revision entry for v3.3.4, replacing the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new revision entry (v3.3.3) to the record history. Removed the HHS Vulnerability Disclosure link and the older revision entry v3.3.2.SummaryDifference0.2%

- Check85 days agoChange DetectedA new site revision entry v3.3.2 appears in the history, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Arimoclomol in Myositis-Open Label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.